お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、SPECT用放射性医薬品の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にSPECT用放射性医薬品市場を分類しています。
本レポートでは世界のSPECT用放射性医薬品市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：GE Healthcare、Cardinal Health、Lantheus Medical Imaging、Bracco Imaging、Curium Pharma、Eczacibasi-Monrol、Siemens Healthineers、Bayer (Radiology Division)、Molecular Imaging, Inc.、NorthStar Medical Radioisotopes、Advanced Accelerator Applications、IBA Molecular Imaging

レポートはSPECT用放射性医薬品の主要生産者を調査し、主要地域や国の消費状況も提供します。SPECT用放射性医薬品の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Technetium-99m (Tc-99m) Based Agents
    Iodine-123 (I-123) Based Agents
    Gallium-67 (Ga-67)
    Indium-111 (In-111) Based Agents
    Thallium-201 (Tl-201)

用途別の市場セグメント：
    Cardiac Imaging
    Cancer Imaging
    Brain Imaging
    Thyroid Imaging
    Infection and Inflammation Imaging

本レポートの詳細内容
本レポートは、世界のSPECT用放射性医薬品市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてSPECT用放射性医薬品市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）のSPECT用放射性医薬品生産量、成長率、市場シェアを調査している。

二. 消費面では、SPECT用放射性医薬品の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのSPECT用放射性医薬品売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のSPECT用放射性医薬品市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本SPECT用放射性医薬品のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：SPECT用放射性医薬品のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： SPECT用放射性医薬品の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおけるSPECT用放射性医薬品の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章SPECT用放射性医薬品メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：SPECT用放射性医薬品の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：SPECT用放射性医薬品の主要メーカーの概要を提供し、製品の説明と仕様、SPECT用放射性医薬品の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：SPECT用放射性医薬品の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Valued at US$ 5954 million in 2024, the global SPECT Radiopharmaceuticals market is forecast to reach US$ 15040 million by 2030, at a CAGR of 16.7% during the forecast period.
SPECT (Single Photon Emission Computed Tomography) radiopharmaceuticals are compounds that contain a radioactive isotope used in conjunction with SPECT imaging techniques. These radiopharmaceuticals emit gamma radiation, which is detected by a gamma camera during a SPECT scan, creating detailed 3D images of the internal structures and functions of the body. These radiopharmaceuticals are primarily used for diagnostic imaging, allowing healthcare providers to evaluate the function of organs, tissues, and systems without invasive procedures.
SPECT radiopharmaceuticals are a type of radioactive tracers used in nuclear medicine imaging that can help doctors detect heart disease, neurological diseases, cancer, bone diseases, and thyroid diseases. They rely on short-half-life radioisotopes to obtain physiological function information through SPECT scanners, and have important applications in modern medicine.
From a regional perspective, North America and Europe have advanced medical infrastructure and strong R&D capabilities. As the world's largest radiopharmaceutical market, they have promoted the widespread use of SPECT radiopharmaceuticals. The increase in medical demand in emerging markets such as Asia Pacific and Latin America will provide new growth momentum for the SPECT radiopharmaceutical market.
Global leading suppliers include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, etc. The production of radiopharmaceuticals requires complex nuclear technology and strict safety supervision. These high technical barriers limit the entry of new companies and maintain the stability of the market.
With the advancement of medical technology, new radioisotopes and labeling methods will be developed to improve the accuracy and efficiency of SPECT imaging and promote market development.

Report Includes
This report presents an overview of global market for SPECT Radiopharmaceuticals market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of SPECT Radiopharmaceuticals, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for SPECT Radiopharmaceuticals, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the SPECT Radiopharmaceuticals revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global SPECT Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for SPECT Radiopharmaceuticals revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, Eczacibasi-Monrol, Siemens Healthineers, Bayer (Radiology Division), Molecular Imaging, Inc., NorthStar Medical Radioisotopes, etc.
Market Segmentation
By Company
    GE Healthcare
    Cardinal Health
    Lantheus Medical Imaging
    Bracco Imaging
    Curium Pharma
    Eczacibasi-Monrol
    Siemens Healthineers
    Bayer (Radiology Division)
    Molecular Imaging, Inc.
    NorthStar Medical Radioisotopes
    Advanced Accelerator Applications
    IBA Molecular Imaging

Segment by Type
    Technetium-99m (Tc-99m) Based Agents
    Iodine-123 (I-123) Based Agents
    Gallium-67 (Ga-67)
    Indium-111 (In-111) Based Agents
    Thallium-201 (Tl-201)

Segment by Application
    Cardiac Imaging
    Cancer Imaging
    Brain Imaging
    Thyroid Imaging
    Infection and Inflammation Imaging

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of SPECT Radiopharmaceuticals in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of SPECT Radiopharmaceuticals companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SPECT Radiopharmaceuticals revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
 Table 1. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Technetium-99m (Tc-99m) Based Agents
 Table 3. Key Players of Iodine-123 (I-123) Based Agents
 Table 4. Key Players of Gallium-67 (Ga-67)
 Table 5. Key Players of Indium-111 (In-111) Based Agents
 Table 6. Key Players of Thallium-201 (Tl-201)
 Table 7. Global SPECT Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global SPECT Radiopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Market Size by Region (2020-2031) & (US$ Million)
 Table 10. Global SPECT Radiopharmaceuticals Market Share by Region (2020-2031)
 Table 11. Market Trends
 Table 12. Market Drivers
 Table 13. Market Challenges
 Table 14. Market Restraints
 Table 15. Global SPECT Radiopharmaceuticals Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global SPECT Radiopharmaceuticals Market Share by Players (2020-2025)
 Table 17. Global Top SPECT Radiopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SPECT Radiopharmaceuticals as of 2024)
 Table 18. Global SPECT Radiopharmaceuticals Industry Ranking 2023 VS 2024
 Table 19. Global 5 Largest Players Market Share by SPECT Radiopharmaceuticals Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of SPECT Radiopharmaceuticals, Headquarters and Area Served
 Table 21. Global Key Players of SPECT Radiopharmaceuticals, Product and Application
 Table 22. Global Key Players of SPECT Radiopharmaceuticals, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2020-2025)
 Table 26. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2026-2031)
 Table 28. Global Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2020-2025)
 Table 30. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2026-2031)
 Table 32. North America Market Size by Type (2020-2031) & (US$ Million)
 Table 33. North America Market Size by Application (2020-2031) & (US$ Million)
 Table 34. North America SPECT Radiopharmaceuticals Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Market Size by Country (2020-2031) & (US$ Million)
 Table 36. Europe Market Size by Type (2020-2031) & (US$ Million)
 Table 37. Europe Market Size by Application (2020-2031) & (US$ Million)
 Table 38. Europe SPECT Radiopharmaceuticals Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Market Size by Country (2020-2025) & (US$ Million)
 Table 40. China Market Size by Type (2020-2031) & (US$ Million)
 Table 41. China Market Size by Application (2020-2031) & (US$ Million)
 Table 42. Asia Market Size by Type (2020-2031) & (US$ Million)
 Table 43. Asia Market Size by Application (2020-2025) & (US$ Million)
 Table 44. Asia SPECT Radiopharmaceuticals Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Asia Market Size by Region (2020-2031) & (US$ Million)
 Table 46. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
 Table 47. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
 Table 48. Middle East, Africa, and Latin America SPECT Radiopharmaceuticals Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
 Table 50. GE Healthcare Company Details
 Table 51. GE Healthcare Business Overview
 Table 52. GE Healthcare SPECT Radiopharmaceuticals Product
 Table 53. GE Healthcare Revenue (2020-2025) & (US$ Million)
 Table 54. GE Healthcare Recent Development
 Table 55. Cardinal Health Company Details
 Table 56. Cardinal Health Business Overview
 Table 57. Cardinal Health SPECT Radiopharmaceuticals Product
 Table 58. Cardinal Health Revenue (2020-2025) & (US$ Million)
 Table 59. Cardinal Health Recent Development
 Table 60. Lantheus Medical Imaging Company Details
 Table 61. Lantheus Medical Imaging Business Overview
 Table 62. Lantheus Medical Imaging SPECT Radiopharmaceuticals Product
 Table 63. Lantheus Medical Imaging Revenue (2020-2025) & (US$ Million)
 Table 64. Lantheus Medical Imaging Recent Development
 Table 65. Bracco Imaging Company Details
 Table 66. Bracco Imaging Business Overview
 Table 67. Bracco Imaging SPECT Radiopharmaceuticals Product
 Table 68. Bracco Imaging Revenue (2020-2025) & (US$ Million)
 Table 69. Bracco Imaging Recent Development
 Table 70. Curium Pharma Company Details
 Table 71. Curium Pharma Business Overview
 Table 72. Curium Pharma SPECT Radiopharmaceuticals Product
 Table 73. Curium Pharma Revenue (2020-2025) & (US$ Million)
 Table 74. Curium Pharma Recent Development
 Table 75. Eczacibasi-Monrol Company Details
 Table 76. Eczacibasi-Monrol Business Overview
 Table 77. Eczacibasi-Monrol SPECT Radiopharmaceuticals Product
 Table 78. Eczacibasi-Monrol Revenue (2020-2025) & (US$ Million)
 Table 79. Eczacibasi-Monrol Recent Development
 Table 80. Siemens Healthineers Company Details
 Table 81. Siemens Healthineers Business Overview
 Table 82. Siemens Healthineers SPECT Radiopharmaceuticals Product
 Table 83. Siemens Healthineers Revenue (2020-2025) & (US$ Million)
 Table 84. Siemens Healthineers Recent Development
 Table 85. Bayer (Radiology Division) Company Details
 Table 86. Bayer (Radiology Division) Business Overview
 Table 87. Bayer (Radiology Division) SPECT Radiopharmaceuticals Product
 Table 88. Bayer (Radiology Division) Revenue (2020-2025) & (US$ Million)
 Table 89. Bayer (Radiology Division) Recent Development
 Table 90. Molecular Imaging, Inc. Company Details
 Table 91. Molecular Imaging, Inc. Business Overview
 Table 92. Molecular Imaging, Inc. SPECT Radiopharmaceuticals Product
 Table 93. Molecular Imaging, Inc. Revenue (2020-2025) & (US$ Million)
 Table 94. Molecular Imaging, Inc. Recent Development
 Table 95. NorthStar Medical Radioisotopes Company Details
 Table 96. NorthStar Medical Radioisotopes Business Overview
 Table 97. NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Product
 Table 98. NorthStar Medical Radioisotopes Revenue (2020-2025) & (US$ Million)
 Table 99. NorthStar Medical Radioisotopes Recent Development
 Table 100. Advanced Accelerator Applications Company Details
 Table 101. Advanced Accelerator Applications Business Overview
 Table 102. Advanced Accelerator Applications SPECT Radiopharmaceuticals Product
 Table 103. Advanced Accelerator Applications Revenue (2020-2025) & (US$ Million)
 Table 104. Advanced Accelerator Applications Recent Development
 Table 105. IBA Molecular Imaging Company Details
 Table 106. IBA Molecular Imaging Business Overview
 Table 107. IBA Molecular Imaging SPECT Radiopharmaceuticals Product
 Table 108. IBA Molecular Imaging Revenue (2020-2025) & (US$ Million)
 Table 109. IBA Molecular Imaging Recent Development
 Table 110. Research Programs/Design for This Report
 Table 111. Key Data Information from Secondary Sources
 Table 112. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 2. Global SPECT Radiopharmaceuticals Market Share by Type: 2024 VS 2031
 Figure 3. Technetium-99m (Tc-99m) Based Agents Features
 Figure 4. Iodine-123 (I-123) Based Agents Features
 Figure 5. Gallium-67 (Ga-67) Features
 Figure 6. Indium-111 (In-111) Based Agents Features
 Figure 7. Thallium-201 (Tl-201) Features
 Figure 8. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Global SPECT Radiopharmaceuticals Market Share by Application: 2024 VS 2031
 Figure 10. Cardiac Imaging Case Studies
 Figure 11. Cancer Imaging Case Studies
 Figure 12. Brain Imaging Case Studies
 Figure 13. Thyroid Imaging Case Studies
 Figure 14. Infection and Inflammation Imaging Case Studies
 Figure 15. SPECT Radiopharmaceuticals Report Years Considered
 Figure 16. Global SPECT Radiopharmaceuticals Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global SPECT Radiopharmaceuticals Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global SPECT Radiopharmaceuticals Market Share by Region: 2024 VS 2031
 Figure 19. Global SPECT Radiopharmaceuticals Market Share by Players in 2024
 Figure 20. Global Top SPECT Radiopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SPECT Radiopharmaceuticals as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by SPECT Radiopharmaceuticals Revenue in 2024
 Figure 22. North America SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America SPECT Radiopharmaceuticals Market Share by Type (2020-2031)
 Figure 24. North America SPECT Radiopharmaceuticals Market Share by Application (2020-2031)
 Figure 25. North America SPECT Radiopharmaceuticals Market Share by Country (2020-2031)
 Figure 26. United States SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe SPECT Radiopharmaceuticals Market Share by Type (2020-2031)
 Figure 30. Europe SPECT Radiopharmaceuticals Market Share by Application (2020-2031)
 Figure 31. Europe SPECT Radiopharmaceuticals Market Share by Country (2020-2031)
 Figure 32. Germany SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. France SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. U.K. SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Italy SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Russia SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Nordic Countries SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. China SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. China SPECT Radiopharmaceuticals Market Share by Type (2020-2031)
 Figure 40. China SPECT Radiopharmaceuticals Market Share by Application (2020-2031)
 Figure 41. Asia SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Asia SPECT Radiopharmaceuticals Market Share by Type (2020-2031)
 Figure 43. Asia SPECT Radiopharmaceuticals Market Share by Application (2020-2031)
 Figure 44. Asia SPECT Radiopharmaceuticals Market Share by Region (2020-2031)
 Figure 45. Japan SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. South Korea SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. China Taiwan SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Southeast Asia SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. India SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Australia SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Middle East, Africa, and Latin America SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Middle East, Africa, and Latin America SPECT Radiopharmaceuticals Market Share by Type (2020-2031)
 Figure 53. Middle East, Africa, and Latin America SPECT Radiopharmaceuticals Market Share by Application (2020-2031)
 Figure 54. Middle East, Africa, and Latin America SPECT Radiopharmaceuticals Market Share by Country (2020-2031)
 Figure 55. Brazil SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 56. Mexico SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 57. Turkey SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 59. Israel SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 60. GCC Countries SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 61. GE Healthcare Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 62. Cardinal Health Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 63. Lantheus Medical Imaging Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 64. Bracco Imaging Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 65. Curium Pharma Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 66. Eczacibasi-Monrol Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 67. Siemens Healthineers Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 68. Bayer (Radiology Division) Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 69. Molecular Imaging, Inc. Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 70. NorthStar Medical Radioisotopes Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 71. Advanced Accelerator Applications Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 72. IBA Molecular Imaging Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed